The primary goal of healthcare providers and pharmaceutical companies is to improve patient outcomes. Accurate patient flow forecasting is critical in achieving this objective.
Professor Andrea Manfrin joined the MHRA in June 2023 as Deputy Director of Clinical Investigations and Trials, to spearhead the regulator’s overhaul of the clinical trial regulations.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.